Impact of Friedreich's Ataxia on health-care resource utilization in the United Kingdom and Germany.

Abstract:

BACKGROUND:Friedreich's Ataxia (FRDA) is a neurodegenerative disorder that causes progressive damage to the central and peripheral nervous systems having a significant impact upon quality of life. With little information in the literature, cross-sectional observational studies were conducted in the UK and Germany to collect data on resource use and the burden of the disease on individuals and their caregivers. METHODS:Cross-sectional observational studies were conducted in the UK and Germany to estimate the burden of FRDA on individuals and on the respective healthcare systems. A total of 75 individuals in the UK and 28 in Germany were recruited to the study. Participants in both countries were asked to complete a Patient and Caregiver Information Form (PCIF), regarding access to, and use of, healthcare resources, and the impact FRDA has on their lifestyle. In Germany, doctors were asked to complete a Patient Record Form (PRF). Analyses of annual direct and indirect resource utilization were conducted for both countries while costs were calculated for the UK only. These figures were compared to the costs associated with Parkinson's disease; one of the most common neurodegenerative conditions and the one most similar in terms of disease progression. RESULTS:The results showed that the annual burden of FRDA is significant and falls on the health and social care sectors, on society, on caregivers and on the individuals themselves. In the UK FRDA had a total annual cost per person of between £11,818 and £18,774 depending on whether the cost of long-term unemployment was included.Typically the largest component of direct costs is associated with professional care. Given the high proportion of children and young adults recruited and the long disease duration, (typically 40-50 years for FRDA, compared with 20 years for Parkinson's disease), these figures may underestimate the true burden of the disease. CONCLUSION:It is hoped that these estimates of resource utilization, can help in understanding the previously unquantified burden of FRDA. Given the long disease duration, management strategies should seek to minimise the impact of the condition on individuals and their caregivers, while maximising quality of life.

journal_name

Orphanet J Rare Dis

authors

Giunti P,Greenfield J,Stevenson AJ,Parkinson MH,Hartmann JL,Sandtmann R,Piercy J,O'Hara J,Casas LR,Smith FM

doi

10.1186/1750-1172-8-38

subject

Has Abstract

pub_date

2013-02-28 00:00:00

pages

38

issn

1750-1172

pii

1750-1172-8-38

journal_volume

8

pub_type

杂志文章
  • Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients.

    abstract:BACKGROUND:Prader-Willi syndrome (PWS) is a complex neurodevelopmental genetic disorder with hypothalamic dysfunction, early morbid obesity with hyperphagia, and specific psychiatric phenotypes including cognitive and behavioural problems, particularly disruptive behaviours and frequent temper outbursts that preclude s...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,随机对照试验

    doi:10.1186/1750-1172-6-47

    authors: Tauber M,Mantoulan C,Copet P,Jauregui J,Demeer G,Diene G,Rogé B,Laurier V,Ehlinger V,Arnaud C,Molinas C,Thuilleaux D

    更新日期:2011-06-24 00:00:00

  • Systemic retinoids for treatment of recalcitrant IgA pemphigus.

    abstract::IgA pemphigus is an exceedingly rare autoimmune blistering disorder, caused by IgA autoantibodies against desmosomal proteins. No treatment option has been found to be universally effective. The disease is often recalcitrant to oral steroids and immunosuppressants. Here, we describe the use of systemic retinoids for t...

    journal_title:Orphanet journal of rare diseases

    pub_type: 信件

    doi:10.1186/s13023-018-0899-y

    authors: Schauer F,Kern JS,Kiritsi D

    更新日期:2018-09-18 00:00:00

  • How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration.

    abstract::Among the challenges confronting patients with rare diseases is a dearth of treatment options. The development of safe and effective new therapies is hampered by challenges associated with conducting clinical trials in small populations. In this article, we describe how the Duchenne muscular dystrophy community-led by...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-015-0281-2

    authors: Furlong P,Bridges JF,Charnas L,Fallon JR,Fischer R,Flanigan KM,Franson TR,Gulati N,McDonald C,Peay H,Sweeney HL

    更新日期:2015-06-24 00:00:00

  • The P42 peptide and Peptide-based therapies for Huntington's disease.

    abstract::Huntington's disease (HD) is a progressive neurodegenerative hereditary disease clinically characterised by the presence of involuntary movements, behavioural problems and cognitive decline. The disease-onset is usually between 30 and 50 years of age. HD is a rare disorder affecting approximately 1.3 in 10,000 people ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-016-0405-3

    authors: Marelli C,Maschat F

    更新日期:2016-03-17 00:00:00

  • Rapamycin and its analogues (rapalogs) for Tuberous Sclerosis Complex-associated tumors: a systematic review on non-randomized studies using meta-analysis.

    abstract:BACKGROUND:Rapamycin has gained significant attention for its potential activity in reducing the size of TSC-associated tumors, thus providing alternative to surgery. This study aimed at determining the efficacy of rapamycin and rapalogs for reducing the size of TSC-associated solid tumors in patients with Tuberous Scl...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,meta分析,评审

    doi:10.1186/s13023-015-0317-7

    authors: Sasongko TH,Ismail NF,Nik Abdul Malik NM,Zabidi-Hussin ZA

    更新日期:2015-08-12 00:00:00

  • Recommendations for the design of small population clinical trials.

    abstract:BACKGROUND:Orphan drug development faces numerous challenges, including low disease prevalence, patient population heterogeneity, and strong presence of paediatric patient populations. Consequently, clinical trials for orphan drugs are often smaller than those of non-orphan drugs, and they require the development of ef...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-018-0931-2

    authors: Day S,Jonker AH,Lau LPL,Hilgers RD,Irony I,Larsson K,Roes KC,Stallard N

    更新日期:2018-11-06 00:00:00

  • Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study.

    abstract:BACKGROUND:The efficacy of thymectomy in patients with non-thymomatous Myasthenia Gravis (MG) is still unclear. Main limitations have been variable outcome definitions, lack of a control group and adjustment for confounding. OBJECTIVE:To study the efficacy of thymectomy in achieving remission or minimal manifestation ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-014-0214-5

    authors: Barnett C,Katzberg HD,Keshavjee S,Bril V

    更新日期:2014-12-24 00:00:00

  • Stakeholder perspectives on clinical research related to therapies for rare diseases: therapeutic misconception and the value of research.

    abstract:BACKGROUND:For many rare diseases, few treatments are supported by strong evidence. Patients, family members, health care providers, and policy-makers thus have to consider whether to accept, recommend, or fund treatments with uncertain clinical effectiveness. They must also consider whether and how to contribute to cl...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01624-0

    authors: Tingley K,Coyle D,Graham ID,Chakraborty P,Wilson K,Potter BK,Canadian Inherited Metabolic Diseases Research Network.

    更新日期:2021-01-12 00:00:00

  • The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.

    abstract::The hyper-IgE syndromes are rare, complex primary immunodeficiencies characterized by clinical manifestation diversity, by particular susceptibility to staphylococcal and mycotic infections as well as by a heterogeneous genetic origin. Two distinct entities--the classical hyper-IgE syndrome which is inherited in an au...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-6-76

    authors: Szczawinska-Poplonyk A,Kycler Z,Pietrucha B,Heropolitanska-Pliszka E,Breborowicz A,Gerreth K

    更新日期:2011-11-15 00:00:00

  • Evaluation of the frequency of non-motor symptoms of Parkinson's disease in adult patients with Gaucher disease type 1.

    abstract:BACKGROUND:Gaucher disease (GD) is caused by deficiency of beta-glucocerebrosidase (GCase) due to biallelic variations in the GBA1 gene. Parkinson's disease (PD) is the second most common neurodegenerative condition. The classic motor symptoms of PD may be preceded by many non-motor symptoms (NMS), which include hyposm...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1079-4

    authors: Wilke MVMB,Dornelles AD,Schuh AS,Vairo FP,Basgalupp SP,Siebert M,Nalin T,Piltcher OB,Schwartz IVD

    更新日期:2019-05-10 00:00:00

  • Evolution of Haemophilia Care in Europe: 10 years of the principles of care.

    abstract:INTRODUCTION:The European principles of care in haemophilia marked their first decade in 2018. These guiding principles were the beginning of the European Haemophilia Consortium (EHC) review of countries' adherence to these principles in 2009, 2012, 2015 and 2018. The aim of this paper was to examine the implementation...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01456-y

    authors: Noone D,O'Mahony B,Peyvandi F,Makris M,Bok A

    更新日期:2020-07-13 00:00:00

  • Ocular lesions in hereditary hemorrhagic telangiectasia: genetics and clinical characteristics.

    abstract:BACKGROUND:The aim of our study is to study the association between eye lesions in Hereditary Hemorrhagic Telangiectasia (HHT) and other signs of the disease, as well as to characterize its genetics. METHODS:A cross-sectional study was conducted of a cohort of 206 patients studied in the HHT Unit of Hospital de Sierra...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01433-5

    authors: Gómez-Acebo I,Prado SR,De La Mora Á,Puente RZ,de la Roza Varela B,Dierssen-Sotos T,Llorca J

    更新日期:2020-06-29 00:00:00

  • Natural history of Barth syndrome: a national cohort study of 22 patients.

    abstract:BACKGROUND:This study describes the natural history of Barth syndrome (BTHS). METHODS:The medical records of all patients with BTHS living in France were identified in multiple sources and reviewed. RESULTS:We identified 16 BTHS pedigrees that included 22 patients. TAZ mutations were observed in 15 pedigrees. The est...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-8-70

    authors: Rigaud C,Lebre AS,Touraine R,Beaupain B,Ottolenghi C,Chabli A,Ansquer H,Ozsahin H,Di Filippo S,De Lonlay P,Borm B,Rivier F,Vaillant MC,Mathieu-Dramard M,Goldenberg A,Viot G,Charron P,Rio M,Bonnet D,Donadieu J

    更新日期:2013-05-08 00:00:00

  • Modelling Gaucher disease progression: long-term enzyme replacement therapy reduces the incidence of splenectomy and bone complications.

    abstract::Long-term complications and associated conditions of type 1 Gaucher Disease (GD) can include splenectomy, bone complications, pulmonary hypertension, Parkinson disease and malignancies. Enzyme replacement therapy (ERT) reverses cytopenia and reduces organomegaly. To study the effects of ERT on long-term complications ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-014-0112-x

    authors: van Dussen L,Biegstraaten M,Dijkgraaf MG,Hollak CE

    更新日期:2014-07-24 00:00:00

  • A guide to writing systematic reviews of rare disease treatments to generate FAIR-compliant datasets: building a Treatabolome.

    abstract:BACKGROUND:Rare diseases are individually rare but globally affect around 6% of the population, and in over 70% of cases are genetically determined. Their rarity translates into a delayed diagnosis, with 25% of patients waiting 5 to 30 years for one. It is essential to raise awareness of patients and clinicians of exis...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01493-7

    authors: Atalaia A,Thompson R,Corvo A,Carmody L,Piscia D,Matalonga L,Macaya A,Lochmuller A,Fontaine B,Zurek B,Hernandez-Ferrer C,Rheinard C,Gómez-Andrés D,Desaphy JF,Schon K,Lohmann K,Jennings MJ,Synofzik M,Riess O,Yaou RB,

    更新日期:2020-08-12 00:00:00

  • Krüppel-like zinc finger proteins in end-stage COPD lungs with and without severe alpha1-antitrypsin deficiency.

    abstract:BACKGROUND:Chronic obstructive pulmonary disease (COPD) is influenced by environmental and genetic factors. An important fraction of COPD cases harbor a major genetic determinant, inherited ZZ (Glu342Lys) α1-antitrypsin deficiency (AATD). A study was undertaken to investigate gene expression patterns in end-stage COPD ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-7-29

    authors: Koczulla AR,Jonigk D,Wolf T,Herr C,Noeske S,Klepetko W,Vogelmeier C,von Neuhoff N,Rische J,Wrenger S,Golpon H,Voswinckel R,Luisetti M,Ferrarotti I,Welte T,Janciauskiene S

    更新日期:2012-05-23 00:00:00

  • Lack of knowledge and misperceptions about thalassaemia among college students in Bangladesh: a cross-sectional baseline study.

    abstract:BACKGROUND:Thalassaemia is a potentially life-threatening yet preventable inherited hemoglobin disorder. Understanding local socio-cultural context and level of public awareness about thalassaemia is pivotal for selecting effective prevention strategies. This study attempted to assess knowledge and perceptions about th...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-1323-y

    authors: Hossain MS,Hasan MM,Raheem E,Islam MS,Al Mosabbir A,Petrou M,Telfer P,Siddiqee MH

    更新日期:2020-02-21 00:00:00

  • Sick leave, disability, and mortality in acute hepatic porphyria: a nationwide cohort study.

    abstract:BACKGROUND:Acute hepatic porphyria (AHP) consists of three rare metabolic disorders. We investigated the risk of long-term sick leave, disability pension, and premature death in individuals with AHP compared to the general population. METHODS:In a nationwide cohort study from 1992 to 2017, records of 333 persons (tota...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1273-4

    authors: Baravelli CM,Aarsand AK,Sandberg S,Tollånes MC

    更新日期:2020-02-21 00:00:00

  • MYH7-related myopathies: clinical, histopathological and imaging findings in a cohort of Italian patients.

    abstract:BACKGROUND:Myosin heavy chain 7 (MYH7)-related myopathies are emerging as an important group of muscle diseases of childhood and adulthood, with variable clinical and histopathological expression depending on the type and location of the mutation. Mutations in the head and neck domains are a well-established cause of h...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-016-0476-1

    authors: Fiorillo C,Astrea G,Savarese M,Cassandrini D,Brisca G,Trucco F,Pedemonte M,Trovato R,Ruggiero L,Vercelli L,D'Amico A,Tasca G,Pane M,Fanin M,Bello L,Broda P,Musumeci O,Rodolico C,Messina S,Vita GL,Sframeli M,Gibe

    更新日期:2016-07-07 00:00:00

  • Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases.

    abstract:BACKGROUND:Inherited epidermolysis bullosa (EB) comprises a highly heterogeneous group of rare diseases characterized by exacerbated skin and/or mucosal fragility and blister formation after minor mechanical trauma. Level of cleavage in the skin, clinical features with immunofluorescence antigen mapping and/or electron...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-016-0489-9

    authors: Montaudié H,Chiaverini C,Sbidian E,Charlesworth A,Lacour JP

    更新日期:2016-08-20 00:00:00

  • Congenital cataract, facial dysmorphism and demyelinating neuropathy (CCFDN) in 10 Czech Gypsy children--frequent and underestimated cause of disability among Czech Gypsies.

    abstract:BACKGROUND:Congenital Cataract Facial Dysmorphism and demyelinating Neuropathy (CCFDN, OMIM 604468) is an autosomal recessive multi-system disorder which was first described in Bulgarian Gypsies in 1999. It is caused by the homozygous founder mutation c.863 + 389C > T in the CTDP1 gene. The syndrome has been described ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-9-46

    authors: Lassuthova P,Sišková D,Haberlová J,Sakmaryová I,Filouš A,Seeman P

    更新日期:2014-04-01 00:00:00

  • Share and protect our health data: an evidence based approach to rare disease patients' perspectives on data sharing and data protection - quantitative survey and recommendations.

    abstract:BACKGROUND:The needs and benefits of sharing health data to advance scientific research and improve clinical benefits have been well documented in recent years, specifically in the field of rare diseases where knowledge and expertise are limited and patient populations are geographically dispersed. Understanding what p...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1123-4

    authors: Courbier S,Dimond R,Bros-Facer V

    更新日期:2019-07-12 00:00:00

  • 20-year follow-up study of Danish HHT patients-survival and causes of death.

    abstract:BACKGROUND:Hereditary Haemorrhagic Telangiectasia (HHT) is a dominantly inheritable disorder, with a wide variety of clinical manifestations due to presence of multiple arteriovenous manifestations. The most common mutations are found in HHT1 (ENG) and HHT2 (ACVRL1) patients, causing alterations in the TGF-β pathway wh...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-016-0533-9

    authors: Kjeldsen A,Aagaard KS,Tørring PM,Möller S,Green A

    更新日期:2016-11-22 00:00:00

  • New insight into clinical heterogeneity and inheritance diversity of FBLN5-related cutis laxa.

    abstract:BACKGROUND:FBLN5-related cutis laxa (CL) is a rare disorder that involves elastic fiber-enriched tissues and is characterized by lax skin and variable systemic involvement such as pulmonary emphysema, arterial involvement, inguinal hernias, hollow viscus diverticula and pyloric stenosis. This type of CL follows mostly ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-021-01696-6

    authors: Gharesouran J,Hosseinzadeh H,Ghafouri-Fard S,Jabbari Moghadam Y,Ahmadian Heris J,Jafari-Rouhi AH,Taheri M,Rezazadeh M

    更新日期:2021-01-28 00:00:00

  • Single point mutation in Rabenosyn-5 in a female with intractable seizures and evidence of defective endocytotic trafficking.

    abstract:BACKGROUND:We report a 6.5 year-old female with a homozygous missense mutation in ZFYVE20, encoding Rabenosyn-5 (Rbsn-5), a highly conserved multi-domain protein implicated in receptor-mediated endocytosis. The clinical presentation includes intractable seizures, developmental delay, microcephaly, dysostosis, osteopeni...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-014-0141-5

    authors: Stockler S,Corvera S,Lambright D,Fogarty K,Nosova E,Leonard D,Steinfeld R,Ackerley C,Shyr C,Au N,Selby K,van Allen M,Vallance H,Wevers R,Watkins D,Rosenblatt D,Ross CJ,Conibear E,Wasserman W,van Karnebeek C

    更新日期:2014-09-20 00:00:00

  • Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis.

    abstract:BACKGROUND:Purine nucleoside analogs (PNAs) are the recommended first-line treatment for patients with hairy cell leukemia (HCL), but they are associated with adverse events (AEs). Due to a lack of real-world evidence regarding AEs that are associated with PNAs, we used commercial data to assess AE rates, AE-related he...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-1325-9

    authors: Epperla N,Pavilack M,Olufade T,Bashyal R,Li J,Kabadi SM,Yuce H,Andritsos L

    更新日期:2020-02-13 00:00:00

  • Anophthalmia and microphthalmia.

    abstract::Anophthalmia and microphthalmia describe, respectively, the absence of an eye and the presence of a small eye within the orbit. The combined birth prevalence of these conditions is up to 30 per 100,000 population, with microphthalmia reported in up to 11% of blind children. High-resolution cranial imaging, post-mortem...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-2-47

    authors: Verma AS,Fitzpatrick DR

    更新日期:2007-11-26 00:00:00

  • Persistent dyslipidemia in treatment of lysosomal acid lipase deficiency.

    abstract:BACKGROUND:Lysosomal acid lipase deficiency (LALD) is an autosomal recessive inborn error of lipid metabolism characterized by impaired lysosomal hydrolysis and consequent accumulation of cholesteryl esters and triglycerides. The phenotypic spectrum is diverse, ranging from severe, neonatal onset failure to thrive, hep...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-1328-6

    authors: Pritchard AB,Strong A,Ficicioglu C

    更新日期:2020-02-24 00:00:00

  • The neonatal tetrahydrobiopterin loading test in phenylketonuria: what is the predictive value?

    abstract:BACKGROUND:It is unknown whether the neonatal tetrahydrobiopterin (BH4) loading test is adequate to diagnose long-term BH4 responsiveness in PKU. Therefore we compared the predictive value of the neonatal (test I) versus the 48-h BH4 loading test (test II) and long-term BH4 responsiveness. METHODS:Data on test I (>199...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-016-0394-2

    authors: Anjema K,Hofstede FC,Bosch AM,Rubio-Gozalbo ME,de Vries MC,Boelen CC,van Rijn M,van Spronsen FJ

    更新日期:2016-01-29 00:00:00

  • Urinary glutamine/glutamate ratio as a potential biomarker of pediatric chronic intestinal pseudo-obstruction.

    abstract::Chronic intestinal pseudo-obstruction (CIPO) is a rare intestinal motility disorder with significant morbidity and mortality in pediatric patients. The diagnosis of CIPO is difficult, because it is clinically based on the symptoms and signs of bowel obstruction which are similar to the clinical manifestations of other...

    journal_title:Orphanet journal of rare diseases

    pub_type: 信件

    doi:10.1186/s13023-017-0615-3

    authors: Yan JK,Zhou KJ,Huang JH,Wu QQ,Zhang T,Wang CC,Cai W

    更新日期:2017-03-28 00:00:00